Using GLOBOCAN estimates, we describe the estimated cancer incidence among adults
aged 80 years or older at the regional and global level in 2018, reporting the number of new …

The 1995 Lung Cancer Study Group consensus recommending lobectomy for stage I non-
small cell lung cancer (NSCLC) has directed lung cancer resections since its publication …

Surgery remains the best curative option in patients with early stage lung cancer (stage I and
II). Developments in minimally invasive techniques now allow surgeons to perform lung …

Background The treatment of stage I and II non-small cell lung cancer (NSCLC) in patients
with good or low surgical risk is primarily surgical resection. However, this area is …

Abstract Introduction The Japanese Joint Committee of Lung Cancer Registry performed the
fourth nationwide registry study of surgical cases. Demographics, safety and quality …

Background The Japan Lung Cancer Society, the Japanese Association for Chest Surgery,
and the Japanese Respiratory Society jointly established the Japanese Joint Committee for …

Objective Lobectomy is a standard treatment for stage I non–small cell lung cancer, but a
significant proportion of patients are considered at high risk for complications, including …

Background The selection of surgeries for patients with stage I NSCLC remains
controversial. We evaluated the effectiveness of different surgeries for stage I NSCLC …

BACKGROUND: Sublobar resection is indicated for early-stage non-small cell lung cancer
in patients with a perioperative risk associated with impaired medical conditions. This study …

Early-stage non-small cell lung cancer (NSCLC) is on the rise due to the implementation of
screening guidelines for patients at risk for developing lung cancer. It is anticipated that as …